Philip Morris International Inc. (PM)
Philip Morris: Strong Sales, Lower Health Risks From Smokeless Products
Philip Morris is shifting towards smoke-free products to reduce harm caused by smoking, aiming for smokeless products to generate over two-thirds of total net revenues by 2030. Strong performance in 2Q with increased demand for Zyn nicotine pouches led to a raised forecast for net income growth. Despite the controversial past, Philip Morris' shares continue to be a strong buy, with impressive revenue growth and transition towards smoke-free products showing promising results.
Philip Morris's Latest Earnings Call Is Boosting the Stock, but Do Tobacco Products Have Long-Term Staying Power?
Management reported a strong Q2 with solid performance from core tobacco and impressive growth from smokeless products. The cigarette business remains in a long-term downtrend.
Philip Morris Gains on Earnings Beat, Raised Outlook
Philip Morris International (PM) shares rose Tuesday to their highest level in more than two years after the tobacco giant posted better-than-expected results and raised its full-year outlook on growing demand for its smokeless products.
Philip Morris (PM) Ups View on Q2 Earnings Beat: Pricing Aids
Philip Morris' (PM) second-quarter 2024 results reflect continued strength in pricing and the company's smoke-free business. Management raises guidance despite adverse currency fluctuations.
Philip Morris International Inc. (PM) Q2 2024 Earnings Call Transcript
Philip Morris International Inc. (NYSE:PM ) Q2 2024 Results Conference Call July 23, 2024 9:00 AM ET Company Participants James Bushnell - VP, IR, and Financial Communications Emmanuel Babeau - Chief Financial Officer Conference Call Participants Gaurav Jain - Barclays Bonnie Herzog - Goldman Sachs Matt Smith - Stifel Faham Baig - UBS Owen Bennett - Jefferies Callum Elliott - Bernstein Priya Ohri-Gupta - Barclays Operator Good day, and thank you for standing by. Welcome to the Philip Morris International Inc. 2024 Second Quarter Results Conference Call.
Philip Morris delays U.S. heated tobacco device pilot to fourth quarter
Philip Morris International pushed the test-launch of its heated tobacco device, IQOS, in the U.S. to the fourth quarter on Tuesday and lowered its annual forecast for the heated tobacco business.
Has Philip Morris International (PM) Outpaced Other Consumer Staples Stocks This Year?
Here is how Philip Morris (PM) and Vital Farms (VITL) have performed compared to their sector so far this year.
Philip Morris (PM) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Philip Morris (PM) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Philip Morris (PM) Tops Q2 Earnings and Revenue Estimates
Philip Morris (PM) came out with quarterly earnings of $1.59 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.60 per share a year ago.
Philip Morris International Conquers The Ever-Changing World
PM's smokeable portfolio is less susceptible to the trends underlying the cigarette volume declines. The Company delivered impressive growth of its smoke-free portfolio and is set to reach its 2030 Vision. I don't see a strong upside through multiple appreciation in the short term. However, PM's long-term owners are highly likely to benefit greatly.
Higher HTU Sales To Drive Philip Morris' Q2?
Philip Morris (NYSE: PM) is scheduled to report its Q2 2024 results on Tuesday, July 23. We expect the company to post revenue and earnings marginally below the consensus estimates.
Health Advocates Target the U.S. Launch of Philip Morris' Heated Tobacco Products. Is the Stock in Trouble?
No less than six health and consumer groups are teaming up to oppose the planned IQOS rollout in this country. They are lobbying the Food and Drug Administration to keep the product off U.S. store shelves.
